LU86966A1 - Orales therapeutisches system mit systemischer wirkung - Google Patents

Orales therapeutisches system mit systemischer wirkung Download PDF

Info

Publication number
LU86966A1
LU86966A1 LU86966A LU86966A LU86966A1 LU 86966 A1 LU86966 A1 LU 86966A1 LU 86966 A LU86966 A LU 86966A LU 86966 A LU86966 A LU 86966A LU 86966 A1 LU86966 A1 LU 86966A1
Authority
LU
Luxembourg
Prior art keywords
core
carbamazepine
therapeutic system
cellulose
water
Prior art date
Application number
LU86966A
Other languages
German (de)
English (en)
Inventor
Satish Chandra Khanna
Theresa Ruettimann
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of LU86966A1 publication Critical patent/LU86966A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
LU86966A 1986-08-07 1987-08-05 Orales therapeutisches system mit systemischer wirkung LU86966A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH317286 1986-08-07
CH3172/86A CH668187A5 (de) 1986-08-07 1986-08-07 Therapeutisches system mit systemischer wirkung.

Publications (1)

Publication Number Publication Date
LU86966A1 true LU86966A1 (fr) 1989-03-08

Family

ID=4250176

Family Applications (1)

Application Number Title Priority Date Filing Date
LU86966A LU86966A1 (fr) 1986-08-07 1987-08-05 Orales therapeutisches system mit systemischer wirkung

Country Status (30)

Country Link
US (1) US4857336A (fr)
JP (1) JP2592460B2 (fr)
KR (1) KR950006219B1 (fr)
AT (1) AT397344B (fr)
AU (1) AU597403B2 (fr)
BE (1) BE1000235A3 (fr)
CA (1) CA1302267C (fr)
CH (1) CH668187A5 (fr)
DD (1) DD285718A5 (fr)
DE (1) DE3725824C2 (fr)
DK (1) DK175497B1 (fr)
ES (1) ES2007100A6 (fr)
FI (1) FI86143C (fr)
FR (1) FR2602425B1 (fr)
GB (1) GB2193632B (fr)
GR (1) GR871234B (fr)
HK (1) HK33793A (fr)
HU (1) HU206978B (fr)
IE (1) IE59718B1 (fr)
IL (1) IL83386A (fr)
IT (1) IT1215618B (fr)
LU (1) LU86966A1 (fr)
MY (1) MY100767A (fr)
NL (1) NL194780C (fr)
NO (1) NO173726C (fr)
NZ (1) NZ221347A (fr)
PH (1) PH25090A (fr)
PT (1) PT85489B (fr)
SE (1) SE502590C2 (fr)
ZA (1) ZA875804B (fr)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0277092B1 (fr) * 1987-01-14 1992-01-29 Ciba-Geigy Ag Système thérapeutique pour médicaments peu solubles
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
US4824675A (en) * 1987-07-13 1989-04-25 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills
NZ226179A (en) * 1987-09-24 1991-04-26 Merck & Co Inc Controlled porosity osmotic pump for sustained release of pharmaceutical agents
US5019397A (en) * 1988-04-21 1991-05-28 Alza Corporation Aqueous emulsion for pharmaceutical dosage form
JP2893191B2 (ja) * 1988-11-08 1999-05-17 武田薬品工業株式会社 放出制御性マトリックス剤
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US5035897A (en) * 1989-09-05 1991-07-30 Alza Corporation Dosage form for delivering soluble or insoluble drugs
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
RU2111663C1 (ru) * 1991-01-16 1998-05-27 Фмк Корпорейшн Твердая сыпучая композиция носителя для активного вещества в твердой дозированной вододиспергируемой форме, способ ее получения и твердая дозированная форма
US5643591A (en) * 1991-01-16 1997-07-01 Fmc Corporation Solid dosage forms
US5326570A (en) * 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
PT621032E (pt) * 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US20040191314A1 (en) * 1994-04-28 2004-09-30 Frank Jao Antiepileptic dosage form and process for protecting antiepileptic drug
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
DE4423078B4 (de) * 1994-07-01 2005-01-13 Awd.Pharma Gmbh & Co. Kg Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung
TW487582B (en) * 1995-08-11 2002-05-21 Nissan Chemical Ind Ltd Method for converting sparingly water-soluble medical substance to amorphous state
US5800832A (en) * 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
US5980942A (en) * 1997-01-23 1999-11-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release matrix tablet formulations of carbamazepine
US6296873B1 (en) 1997-01-23 2001-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release delivery system for carbamazephine derivatives
CO4920215A1 (es) * 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
US20020022056A1 (en) 1997-02-14 2002-02-21 Burkhard Schlutermann Oxacarbazepine film-coated tablets
CN1623533A (zh) 1997-09-25 2005-06-08 拜尔公司 控释活性化合物的药物制剂
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
CA2329128C (fr) * 1998-04-29 2008-03-18 Virotex Corporation Dispositif de livraison pharmaceutique concu pour la livraison de composes pharmaceutiques aux surfaces muqueuses
US6706283B1 (en) 1999-02-10 2004-03-16 Pfizer Inc Controlled release by extrusion of solid amorphous dispersions of drugs
CA2434169C (fr) * 2001-01-12 2011-03-15 Sun Pharmaceutical Industries Limited Systeme de liberation espacee de medicaments
IN190699B (fr) * 2001-02-02 2003-08-16 Sun Pharmaceutical Ind Ltd
EP1377276B1 (fr) * 2001-04-10 2011-10-05 Sun Pharma Advanced Research Company Limited Composition a liberation par impulsion reglee dans le temps
TW200302748A (en) * 2002-02-01 2003-08-16 Pfizer Prod Inc Osmotic delivery system
US20030161882A1 (en) * 2002-02-01 2003-08-28 Waterman Kenneth C. Osmotic delivery system
US6572889B1 (en) 2002-03-07 2003-06-03 Noveon Ip Holdings Corp. Controlled release solid dosage carbamazepine formulations
WO2003075830A2 (fr) * 2002-03-14 2003-09-18 Sun Pharmaceutical Industries Limited Système de délivrance contrôlée de médicament par voie orale
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en) * 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) * 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
US20060210633A1 (en) * 2003-04-03 2006-09-21 Sun Pharmaceutical Industries Limited Programmed drug delivery system
EP1690540A1 (fr) * 2005-02-15 2006-08-16 Neuro3D Composition comprenant l'ocapéridone
CA2605792A1 (fr) * 2005-04-25 2006-11-02 Teva Pharmaceuticals Usa, Inc. Preparations a liberation prolongee
US20070071819A1 (en) * 2005-05-30 2007-03-29 Kesarwani Amit K Multiple unit modified release compositions of carbamazepine and process for their preparation
SI2054031T1 (sl) 2006-07-21 2016-09-30 Biodelivery Sciences International, Inc. Transmukozne naprave za administracijo z izboljšanim vnosom
US20090143362A1 (en) * 2007-12-04 2009-06-04 Barabde Umesh Vinayakrao Carbamazepine formulations
US9724362B2 (en) * 2007-12-06 2017-08-08 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
WO2009073216A1 (fr) 2007-12-06 2009-06-11 Bend Research, Inc. Nanoparticules comprenant un polymère non ionisable et un copolymère de méthacrylate fonctionnalisé par amine
WO2013026064A1 (fr) 2011-08-18 2013-02-21 Biodelivery Sciences International, Inc. Dispositifs mucoadhésifs anti-abus destinés à administrer de la buprénorphine
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4431641A (en) * 1980-10-17 1984-02-14 Ciba-Geigy Corporation Pharmaceutical compositions having antiepileptic and antineuralgic action
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
CH649080A5 (de) * 1981-04-16 1985-04-30 Ciba Geigy Ag 5h-dibenz(b,f)azepin-5-carboxamide als mittel zur prophylaxe und behandlung von zerebraler leistungsinsuffizienz.
US4553973A (en) * 1982-07-12 1985-11-19 Alza Corporation Process for preparing osmotic device
GB2150830B (en) * 1983-12-05 1987-08-19 Alza Corp Drug dispenser
US4716031A (en) * 1984-03-21 1987-12-29 Alza Corporation Drug dispenser comprising a multiplicity of members acting together for successfully dispensing drug
US4685918A (en) * 1985-02-01 1987-08-11 Merck & Co., Inc. Lipid osmotic pump

Also Published As

Publication number Publication date
FI86143B (fi) 1992-04-15
AT397344B (de) 1994-03-25
GB2193632B (en) 1990-04-25
DK410787D0 (da) 1987-08-06
AU7661787A (en) 1988-02-11
NO173726B (no) 1993-10-18
DE3725824C2 (de) 1998-12-17
PT85489B (pt) 1990-06-29
HU206978B (en) 1993-03-01
IL83386A (en) 1992-01-15
NO873298L (no) 1988-02-08
FR2602425B1 (fr) 1990-09-14
SE502590C2 (sv) 1995-11-20
NL8701857A (nl) 1988-03-01
IL83386A0 (en) 1987-12-31
JP2592460B2 (ja) 1997-03-19
GB8717643D0 (en) 1987-09-03
MY100767A (en) 1991-02-14
NO173726C (no) 1994-01-26
NL194780B (nl) 2002-11-01
IT8748270A0 (it) 1987-08-05
BE1000235A3 (fr) 1988-09-20
FI873409A (fi) 1988-02-08
JPS6344525A (ja) 1988-02-25
AU597403B2 (en) 1990-05-31
US4857336A (en) 1989-08-15
ES2007100A6 (es) 1989-06-01
NZ221347A (en) 1989-12-21
NL194780C (nl) 2003-03-04
KR880002511A (ko) 1988-05-09
PH25090A (en) 1991-02-19
HK33793A (en) 1993-04-16
SE8703034D0 (sv) 1987-08-03
HUT44930A (en) 1988-05-30
FI86143C (fi) 1992-07-27
DD285718A5 (de) 1991-01-03
DE3725824A1 (de) 1988-02-11
NO873298D0 (no) 1987-08-06
CA1302267C (fr) 1992-06-02
IT1215618B (it) 1990-02-22
ZA875804B (en) 1988-02-08
GR871234B (en) 1987-12-08
DK410787A (da) 1988-02-08
ATA199387A (de) 1993-08-15
DK175497B1 (da) 2004-11-15
GB2193632A (en) 1988-02-17
SE8703034L (sv) 1988-02-08
CH668187A5 (de) 1988-12-15
PT85489A (en) 1987-09-01
KR950006219B1 (ko) 1995-06-12
FR2602425A1 (fr) 1988-02-12
IE872110L (en) 1988-02-07
FI873409A0 (fi) 1987-08-05
IE59718B1 (en) 1994-03-23

Similar Documents

Publication Publication Date Title
AT397344B (de) Verfahren zur herstellung eines oralen therapeutischen systems für carbamazepin
EP0277092B1 (fr) Système thérapeutique pour médicaments peu solubles
EP0339506B1 (fr) Système osmotique oral avec adhésion améliorée de la membrane au noyau
EP1024793B1 (fr) Systeme osmotique de liberation de medicament
DE60038698T2 (de) Hydrogel-gesteuerte dosierungsform
DE69738089T2 (de) Feste orale Dosierungsformen enthaltend Valsartan
DE69909801T2 (de) Oral verabreichtes system zur zeitlich und räumlich gesteuerten arzneistoffabgabe
DE19681389B3 (de) Dosierungsform, umfassend Oxybutynin
DE69832092T2 (de) VERBESSERTE HMG CoA REDUKTASE-INHIBITOR FORMULIERUNG MIT VERLÄNGERTER FREISETZUNG
DE69910803T2 (de) Fentanylzusammensetzung zur behandlung von akutem schmerz
DE60123384T2 (de) Dosierungsform des typs "hülle und kern" mit einer wirkstofffreisetzung, die sich der nullten ordnung annähert
DE60101581T2 (de) Tablettenform zur gastrischen zurückhaltungssteigerung wasserquellfähiger mit kontrollierter freisetzung oraler dosierungsformen
DE60125142T2 (de) Osmotische vorrichtung mit einer vorgeformten durchlassöffnung, deren grösse zunimmt
EP0720473B1 (fr) Pellets de budesonide a liberation controlee et leur procede de preparation
DE3407873C2 (fr)
DE69924710T2 (de) Pharmazeutische zubereitung zur anwendung in der antiasthmatherapie
DE69627170T2 (de) Nichtwässrige abführmittel für den kolon
DE60019334T2 (de) Antivirale arznei
EP1410793B1 (fr) Composition pharmaceutique d'ibuprofène
DE102004062475A1 (de) Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
DE2907215A1 (de) Feste depotarzneimittelpraeparate und verfahren zu deren herstellung
DE69530759T2 (de) Filmbeschichtete tablette, die paracetamol und domperidone enthält
DE19530575A1 (de) Schnell zerfallende Arzneiform von Tramadol oder einem Tramadolsalz
DE3909520A1 (de) Feste, schnell zerfallende darreichungsformen
EP0765158B1 (fr) Excipient destine a la liberation controlee de principes actifs dans le tractus gastro-intestinal avec passage retarde dans le pylore

Legal Events

Date Code Title Description
DT Application date
TA Annual fee